InsidersTradesSigma
Follow the PRO MEDICUS LIMITED stock price and the full management transaction log of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Market capitalisation: €18.7bn. The latest transaction was reported on 7 September 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. The full history is openly available.
Analysts rate PRO MEDICUS LIMITED Buy (bullish), based on 15 analysts. Average price target: A$202.47.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
PRO MEDICUS LIMITED es una empresa australiana especializada en soluciones de software para imágenes médicas. Proporciona herramientas para mejorar la eficiencia y la calidad de los servicios de atención médica.